spacer
home > pmps > summer 2007 > leaning the right way
PUBLICATIONS
Pharmaceutical Manufacturing and Packing Sourcer

Leaning The Right Way

Daniel Nash, Process Specialist at London MAS, claims we can reduce waste in the pharmaceutical industry by learning the true value of lean manufacturing

Would it surprise you to learn that 95 per cent of the time taken from order receipt to despatch of goods adds no value to your product? It is estimated that in a typical manufacturing process anything from 0.05 to five per cent of the total time spent on production actually adds value.

Lean manufacturing is the title given to a range of simple yet effective techniques that aim to slash ‘non-value adding’ activity at little or no cost. The techniques are neither new nor technically complex and they are not expensive, but they punch above their weight. They are able to make dramatic improvements in productivity and reductions in lead-times very quickly. For example, average improvements in productivity in excess of 40 per cent and a reduction in leadtime of 60 per cent are not unusual from just one week of intense activity.

Companies wishing to go lean need to grasp four points in order to be successful:

  • A management team who understands and is committed to the process
  • A clear vision of why they must change
  • An ‘action centre’ approach to improvement
  • An initial project on which to ‘cut their teeth’

This article is intended as an introduction to some of the principles and tools that can be applied to pharmaceutical processes. The good news is that such change should not involve laying out large amounts of money on an expensive new plant. All it requires is full-blooded support from all members of staff from the shop floor to board level.

Let’s look at some of the characteristics of lean that are most relevant to the pharmaceutical and packaging industries. John Bicheno, in his ‘Lean Toolbox’, identifies 15 ‘themes’ of lean that distil the essence of the philosophy. The book is recommended to those who would like to take their investigation further, but some of these themes hold a special resonance.


Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
Daniel Nash is an engineering graduate with industrial experience in both the automotive supply and electronics industries. He has been successfully involved in programmes focused on process improvement, supply -chain development and market development. Daniel is a process specialsit for the London Manufacturing Advisory Service (LMAS). The Manufacturing Advisory Service is an initiative set up by the Department for Trade and Industry (DTI), and now comes under the remit of the Department for Business, Enterprise and Regulatory Reform (DBERR). Daniel is currently studying for an MSc in Technology Management.
spacer
Daniel Nash
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

Janssen Announces Phase 1 Results for Bispecific Antibody Amivantamab in the Treatment of Patients with Advanced Non-Small Cell Lung Cancer Harbouring Exon 20 Insertion Mutations

The Janssen Pharmaceutical Companies of Johnson & Johnson today announced results from the Phase 1 CHRYSALIS study evaluating amivantamab (JNJ-6372) in the treatment of patients with advanced non-small cell lung cancer (NSCLC) with epidermal growth factor receptor (EGFR) Exon 20 insertion mutations. Amivantamab is an EGFR and MET-targeted bispecific antibody, which targets activating and resistance EGFR mutations, and MET pathway activation.
More info >>

White Papers

The Key To Tableting Success: How To Choose The Right Tooling

Natoli Engineering Company, Inc.

Choosing the right tooling can increase tablet output, decrease waste and ultimately determine the success of a product launch.
More info >>

 
Industry Events

World Vaccine Congress Washington

27-29 September 2020, Walter E Washington Convention Center, Washington, US

The World Vaccine Congress is an award-winning series of conferences and exhibitions that have grown to become the largest and most established vaccine meeting of its kind across the globe. Our credibility is show through the prestigious scientific advisory board that spend months of hard work creating a new and topical agenda, year on year.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement